T. Guillaume , S. Porcheron , F. Audat , N. Bancillon , A. Berceanu , A. Charbonnier , R. Dulery , N. Edy , J. El Cheikh , E. Hermet , N. Maurer , F. Paul , J. Konopacki-Potet , P. Turlure , A. Wallart , F. Boulanger , N. Dhédin , F. Suarez , I. Yakoub-Agha
{"title":"SFGM-TC对同种异体造血干细胞移植后供体淋巴细胞(DLI)的预防、预防和治疗注射的建议","authors":"T. Guillaume , S. Porcheron , F. Audat , N. Bancillon , A. Berceanu , A. Charbonnier , R. Dulery , N. Edy , J. El Cheikh , E. Hermet , N. Maurer , F. Paul , J. Konopacki-Potet , P. Turlure , A. Wallart , F. Boulanger , N. Dhédin , F. Suarez , I. Yakoub-Agha","doi":"10.1016/j.patbio.2014.05.011","DOIUrl":null,"url":null,"abstract":"<div><p>In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the fourth annual series of workshops which brought together practitioners from all member centers and took place in September 2013 in Lille. Here, we report our recommendations regarding the use of donor lymphocyte injection (DLI) in the prophylactic, pre-emptive and curative settings. This work has been limited to allogeneic stem cell transplantations from an HLA-matched (10/10) or -one antigen-mismatched (9/10) donor.</p></div>","PeriodicalId":19743,"journal":{"name":"Pathologie-biologie","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2014-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.patbio.2014.05.011","citationCount":"14","resultStr":"{\"title\":\"Recommandations de la SFGM-TC concernant l’injection prophylactique, préemptive et curative des lymphocytes du donneur (DLI) après allogreffe de cellules souches hématopoïétiques\",\"authors\":\"T. Guillaume , S. Porcheron , F. Audat , N. Bancillon , A. Berceanu , A. Charbonnier , R. Dulery , N. Edy , J. El Cheikh , E. Hermet , N. Maurer , F. Paul , J. Konopacki-Potet , P. Turlure , A. Wallart , F. Boulanger , N. Dhédin , F. Suarez , I. Yakoub-Agha\",\"doi\":\"10.1016/j.patbio.2014.05.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the fourth annual series of workshops which brought together practitioners from all member centers and took place in September 2013 in Lille. Here, we report our recommendations regarding the use of donor lymphocyte injection (DLI) in the prophylactic, pre-emptive and curative settings. This work has been limited to allogeneic stem cell transplantations from an HLA-matched (10/10) or -one antigen-mismatched (9/10) donor.</p></div>\",\"PeriodicalId\":19743,\"journal\":{\"name\":\"Pathologie-biologie\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.patbio.2014.05.011\",\"citationCount\":\"14\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pathologie-biologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0369811414000716\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathologie-biologie","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0369811414000716","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Recommandations de la SFGM-TC concernant l’injection prophylactique, préemptive et curative des lymphocytes du donneur (DLI) après allogreffe de cellules souches hématopoïétiques
In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the fourth annual series of workshops which brought together practitioners from all member centers and took place in September 2013 in Lille. Here, we report our recommendations regarding the use of donor lymphocyte injection (DLI) in the prophylactic, pre-emptive and curative settings. This work has been limited to allogeneic stem cell transplantations from an HLA-matched (10/10) or -one antigen-mismatched (9/10) donor.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
